Modulation of PDGF mediated osteoblast chemotaxis by leukemia inhibitory factor (LIF).
Cell migration is a key event in tissue repair and remodeling. PDGF, a growth factor for multiple target cells, has been shown to be a potent chemoattractant for a variety of mesenchymal cells. However, it is likely that PDGF-mediated cell migration will be influenced by other cytokines that can be produced during physiological and pathological conditions. Leukemia inhibitory factor (LIF), a cytokine that is produced by a variety of cells including osteoblasts, may promote bone formation, but the mechanism is not known. Since osteoblasts are responsible for laying down new matrix during skeletal remodeling, in this report we have examined whether PDGF or LIF influences the migration of osteoblasts. Among several cytokines and growth factors tested, only PDGF was able to elicit a major chemotactic (directed migration) and a minor chemokinetic (random-migration) response in osteoblasts. LIF alone was not active in either chemotaxis or chemokinesis but when included with PDGF it caused a reduction in chemokinesis. Further, pretreatment of osteoblasts with LIF caused an increase in PDGF-driven chemotaxis. Finally, osteoblasts exposed briefly to LIF synthesized a higher level of non-collagenous proteins upon further treatment with PDGF. These observations are consistent with a role for LIF in promoting bone formation, both by influencing directional migration of osteoblasts and in laying down new matrix.
Chandrasekhar
S
S
Endocrine Division, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA.
Harvey
A K
AK
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001857:Bone Matrix / Q000378:metabolism; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte; D003094:Collagen / Q000096:biosynthesis; D016207:Cytokines / Q000502:physiology; D005353:Fibronectins / Q000096:biosynthesis; D006131:Growth Inhibitors / Q000494:pharmacology*; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000494:pharmacology*; D010006:Osteoblasts / Q000166:cytology*; D015675:Osteocalcin / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D051381:Rats; D011994:Recombinant Proteins
D016207:Cytokines; D005353:Fibronectins; D006131:Growth Inhibitors; D006133:Growth Substances; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D010982:Platelet-Derived Growth Factor; D011994:Recombinant Proteins; D015675:Osteocalcin; D003094:Collagen; D000469:Alkaline Phosphatase